Categories AlphaGraphs, Earnings, Health Care

Johnson & Johnson (JNJ) beats market estimates in Q4

Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2020 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported fourth-quarter revenue of $22.5 billion, up 8% year-over-year, and higher than the Wall Street projection. Net income of $1.86 per share also topped the target that analysts had anticipated.

JNJ shares rose 1.8% immediately following the announcement. The stock has gained 11% in the trailing 12 months.  

Johnson & Johnson Q4 2020 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Johnson & Johnson Q4 earnings call transcript

“We continue to progress our COVID-19 vaccine candidate and look forward to sharing details from our Phase 3 study soon. Johnson & Johnson was built for times like these, and I am extremely confident in our ability to deliver lasting value and continued innovation in 2021 and for years to come,” CEO Alex Gorsky said in a statement.

Prior performance

Most Popular

McDonald’s (MCD) Earnings: Q2 profit jumps and tops expectations on 57% sales growth

McDonald’s Corporation (NYSE: MCD) Wednesday reported stronger-than-expected earnings and revenues for the second quarter of 2021. The fast-food chain reported revenues of $5.89 billion for the June quarter, up 57%

Key highlights from Shopify Q2 earnings: Infographic

Shopify (NYSE: SHOP) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The ecommerce giant reported Q2 revenue of $1.12 billion, up 57% year-over-year and higher than

Infographic: How Pfizer (PFE) performed in Q2 2021

Pfizer Inc. (NYSE: PFE) reported second quarter 2021 earnings results today. Total revenue increased 92% year-over-year to $19 billion. GAAP net income increased 59% YoY to $5.5 billion, or $0.98

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top